ro 22-4839 has been researched along with calmidazolium in 1 studies
*calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin [MeSH]
*calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrand, H; Lundquist, B | 1 |
1 other study(ies) available for ro 22-4839 and calmidazolium
| Article | Year |
|---|---|
Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner.
Topics: Amino Acid Isomerases; Basophils; Benzimidazoles; Calmodulin; Carrier Proteins; Diacylglycerol Kinase; Felodipine; Histamine Release; Humans; Imidazoles; Isoquinolines; Peptidylprolyl Isomerase; Phenothiazines; Phosphotransferases; Pyrimidinones; Tacrolimus; Thiazoles | 1992 |